CompanyTechnologyPartneringCustomersCareersContactnews
BioSeek Drug Discovery
content box headings
BioSeek is harnessing the predictive power of human disease models to fundamentally improve the productivity of drug development

 

 
BioMAP® Systems are integrated cell systems that generate a unique signature of human biological response for prediction of mechanisms and therapeutic efficacy

May 20, 2008 BioSeek will evaluate Merck Serono small molecule compounds and proteins across multiple therapeutic areas in support of target differentiation, lead selection, and nomination of candidates for preclinical development at Merck Serono.

(Read More...)



April 29, 2008 BioSeek Initiates Research Collaboration with Lexicon Pharmaceuticals, Inc.

(Read More...)



April 1, 2008 In the news: "You, In A Dish".

(Click for Science News article)



February 5, 2008 BioSeek, Inc. today announced that Roy A. Whitfield has been elected executive chairman of the Company's board of directors. Mr. Whitfield had joined BioSeek's board of directors and served as a business advisor to the Company since November, 2005.
(Read More...)



January 24, 2008 BioSeek, Inc., announced today that it has entered into a collaboration agreement with Dainippon Sumitomo Pharma Co. (DSP), a global biopharmaceutical leader based in Japan.
(Read More...)